These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26228232)

  • 1. Relief Effect of Bevacizumab on Severe Edema Induced by Re-irradiation in Brain Tumor Patients.
    Shen G; Wang YJ; Guan YJ; Dong DP; Yang G; Li D; Hao RM; Sun HR; Zhou M; Wang KP; Zhou SX; Wang QW; Wu SK; Zeng YJ
    Chin Med J (Engl); 2015 Aug; 128(15):2126-9. PubMed ID: 26228232
    [No Abstract]   [Full Text] [Related]  

  • 2. Bevacizumab-Based Therapy for Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Preliminary Results.
    Zustovich F; Ferro A; Lombardi G; Farina P; Zagonel V
    Chemotherapy; 2014; 60(5-6):294-9. PubMed ID: 25999127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab preconditioning followed by Etoposide and Cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy.
    Lu YS; Chen TW; Lin CH; Yeh DC; Tseng LM; Wu PF; Rau KM; Chen BB; Chao TC; Huang SM; Huang CS; Shih TT; Cheng AL;
    Clin Cancer Res; 2015 Apr; 21(8):1851-8. PubMed ID: 25700303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study.
    Besse B; Le Moulec S; Mazières J; Senellart H; Barlesi F; Chouaid C; Dansin E; Bérard H; Falchero L; Gervais R; Robinet G; Ruppert AM; Schott R; Léna H; Clément-Duchêne C; Quantin X; Souquet PJ; Trédaniel J; Moro-Sibilot D; Pérol M; Madroszyk AC; Soria JC
    Clin Cancer Res; 2015 Apr; 21(8):1896-903. PubMed ID: 25614446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients.
    Niyazi M; Jansen NL; Rottler M; Ganswindt U; Belka C
    Radiat Oncol; 2014 Dec; 9():299. PubMed ID: 25529015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab therapy may contribute to irradiation deferral in patients with breast cancer and with central nervous system metastases: findings of a case series.
    Kountourakis P; Dokou A; Kardara E; Kaltsas S; Doufexis D; Tzovaras A; Mourgela S; Ardavanis A
    Clin Breast Cancer; 2012 Aug; 12(4):282-6. PubMed ID: 22609269
    [No Abstract]   [Full Text] [Related]  

  • 7. Longitudinal brain imaging of five malignant glioma patients treated with bevacizumab using susceptibility-weighted magnetic resonance imaging at 7 T.
    Grabner G; Nöbauer I; Elandt K; Kronnerwetter C; Woehrer A; Marosi C; Prayer D; Trattnig S; Preusser M
    Magn Reson Imaging; 2012 Jan; 30(1):139-47. PubMed ID: 21982163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reirradiation].
    Oh RJ
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2017; 73(10):1069-1074. PubMed ID: 29057779
    [No Abstract]   [Full Text] [Related]  

  • 9. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab.
    Zhong J; Ali AN; Voloschin AD; Liu Y; Curran WJ; Crocker IR; Shu HK
    Cancer; 2015 May; 121(9):1456-62. PubMed ID: 25557543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment.
    Yamasaki F; Kurisu K; Aoki T; Yamanaka M; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Sugiyama K
    Eur J Radiol; 2012 Oct; 81(10):2805-10. PubMed ID: 22100373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
    Norden AD; Young GS; Setayesh K; Muzikansky A; Klufas R; Ross GL; Ciampa AS; Ebbeling LG; Levy B; Drappatz J; Kesari S; Wen PY
    Neurology; 2008 Mar; 70(10):779-87. PubMed ID: 18316689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases.
    Socinski MA; Langer CJ; Huang JE; Kolb MM; Compton P; Wang L; Akerley W
    J Clin Oncol; 2009 Nov; 27(31):5255-61. PubMed ID: 19738122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemetrexed-induced eyelid edema in lung cancer.
    Martins-Filho PR; Kameo SY; Mascarenhas-Oliveira AC; Vieira NF; Azevedo E
    J Craniofac Surg; 2013 Jul; 24(4):e401-3. PubMed ID: 23851735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with recurrent glioblastoma. Preliminary experience.
    D'Alessandris QG; Montano N; Cenci T; Martini M; Lauretti L; Bianchi F; Larocca LM; Maira G; Fernandez E; Pallini R
    Acta Neurochir (Wien); 2013 Jan; 155(1):33-40. PubMed ID: 23132371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in the apparent diffusion coefficient in peritumoral edema for the assessment of recurrent glioblastoma treated by bevacizumab.
    Takano S; Kimu H; Tsuda K; Osuka S; Nakai K; Yamamoto T; Ishikawa E; Akutsu H; Matsuda M; Matsumura A
    Acta Neurochir Suppl; 2013; 118():185-9. PubMed ID: 23564129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab has differential and dose-dependent effects on glioma blood vessels and tumor cells.
    von Baumgarten L; Brucker D; Tirniceru A; Kienast Y; Grau S; Burgold S; Herms J; Winkler F
    Clin Cancer Res; 2011 Oct; 17(19):6192-205. PubMed ID: 21788357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metyrapone incombination with spironolactone and prednisone in the therapy of severe edema].
    Christensen BE
    Nord Med; 1968 Aug; 80(33):1084-90. PubMed ID: 5685665
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of bumetanide on photodynamic therapy-induced peri-tumor edema of C6 glioma xenografts.
    Zhang X; Cong D; Shen D; Gao X; Chen L; Hu S
    Lasers Surg Med; 2014 Jul; 46(5):422-30. PubMed ID: 24700489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of bevacizumab chemotherapy on craniotomy wound healing.
    Clark AJ; Butowski NA; Chang SM; Prados MD; Clarke J; Polley MY; Sughrue ME; McDermott MW; Parsa AT; Berger MS; Aghi MK
    J Neurosurg; 2011 Jun; 114(6):1609-16. PubMed ID: 21142749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.